A series of 7,8-fused tricyclic coumarin derivatives (6a–s) were synthesized.
Compounds were evaluated for AChE, BuChE, ABTS inhibitory and neuroprotective activities.
Most compounds had potent and selective anti AChE activity superior to galantamine.
N-(3-bromobenzyl) derivative 6n had excellent anti-AChE and antioxidant profile.
Kinetic and docking studies showed dual binding site ability of 6n to inhibit AChE.